TATE & LYLE TO INVEST IN EUROPE’S FIRST POLYDEXTROSE PRODUCTION LINE
Tate Lyle has today announced that it will invest in the creation of a new Polydextrose production line at its Koog plant in the Netherlands. The facility will be the first of its kind in Europe, with the capacity to manufacture a range of different soluble fibres.
Tate Lyle’s latest consumer research reveals that 2 out of 3 European consumers think more often about eating a healthy diet than they did 2 years ago. Consumers agree that fibre can bring many health benefits, and that it is particularly beneficial in maintaining digestive health. In addition, health authorities recognize that consumers globally are not meeting the recommended daily intake of fibre.
In recent years Polydextrose has become popular in food and drinks helping consumers to achieve a better balanced and healthier diet.
Polydextrose is low calorie with versatile bulking properties to maintain taste and texture when full calorie carbohydrates are removed from a food. It has a high fibre content giving manufacturers opportunity to add fibre functionality to ‘no added sugar’ and ‘reduced calorie’ food and drinks.
Easy to use and acid stable, Polydextrose is widely represented in various categories such as beverages, dairy and bakery.
Commenting at the launch of Tate Lyle’s new Health and Wellness Innovation Centre in Lille, Caroline Sanders, Marketing Director Food Industrial Ingredients Europe, said:
"We are very excited about the investment. This is the first time that a Polydextrose line will be created in Europe and it reiterates Tate Lyle’s ongoing commitment to better serving the needs of our customers.
The fact that we will be building a new production line in Europe demonstrates our determination to not only maintain and improve our current position in the fibre market, but to also intensify our focus on Health Wellness solutions."
- ends -
Tate Lyle operates through two global business units, Speciality Food Ingredients and Bulk Ingredients, supported by Innovation and Commercial Development. The Group's strategy is to become the leading global provider of Speciality Food Ingredients through a disciplined focus on growth, and by driving the Bulk Ingredients business for sustained cash generation to fuel this growth.
Speciality Food Ingredients include starch-based speciality ingredients (corn-based speciality starches, sweeteners and fibres), no calorie sweeteners (including SPLENDA® Sucralose) and Food Systems which provides blended ingredient solutions. Bulk Ingredients include corn-based bulk sweeteners, industrial starches and fermentation products (primarily acidulants). The co-products from both divisions are primarily sold as animal feed.
Tate Lyle is listed on the London Stock Exchange under the symbol TATE.L. American Depositary Receipts trade under TATYY. In the year to 31 March 2012, Tate Lyle sales totalled £3.1 billion. http://www.tateandlyle.com. SPLENDA® is a trademark of McNeil Nutritionals, LLC
Legal Disclaimer:
EIN Presswire provides this news content "as is" without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the author above.
